×
About 19,038 results

ALLMedicine™ Pulmonary Embolism Center

Research & Reviews  6,327 results

Anticoagulants for acute ischaemic stroke.
https://doi.org/10.1002/14651858.CD000024.pub5
The Cochrane Database of Systematic Reviews; Wang X, Ouyang M et. al.

Oct 23rd, 2021 - Stroke is the third leading cause of early death worldwide. Most ischaemic strokes are caused by a blood clot blocking an artery in the brain. Patient outcomes might be improved if they are offered anticoagulants that reduce their risk of developi...

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients
https://clinicaltrials.gov/ct2/show/NCT04824729

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Rational Use of Screening and Diagnostic Tests
http://emedicine.medscape.com/article/773832-overview

Oct 19th, 2021 - Overview Diagnostic tests help physicians revise disease probability for their patients. When ordering a test, the physician should always do so in order to answer a specific question. The 5 main reasons for a diagnostic test are as follows: Estab...

α1 -antitrypsin Z allele and risk of venous thromboembolism in the general population.
https://doi.org/10.1111/jth.15556
Journal of Thrombosis and Haemostasis : JTH; Riis J, Nordestgaard BG et. al.

Oct 19th, 2021 - The α1 -antitrypsin Z (rs28929474) allele may lead to alterations in hemostasis either through liver disease or effects on coagulation factors. To test the hypothesis that the α1 -antitrypsin Z genetic variant is associated with increased risk of ...

see more →

Guidelines  23 results

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Management of Acute Pulmonary Embolism.
https://doi.org/10.1001/jama.2020.3905
JAMA Paul JD, Cifu AS

Aug 12th, 2020 - Management of Acute Pulmonary Embolism.|2020|Paul JD,Cifu AS,|administration & dosage,administration & dosage,standards,diagnosis,mortality,therapy,standards,standards,standards,adverse effects,methods,mortality,standards,complications,therapy,

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

see more →

Drugs  243 results see all →

Clinicaltrials.gov  125 results

A Study Related to the VOYAGER PAD Trial to Learn More About the Target Population for Xarelto in French Patients
https://clinicaltrials.gov/ct2/show/NCT04824729

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
https://clinicaltrials.gov/ct2/show/NCT03395639

Oct 15th, 2021 - The primary objective is to compare the safety of edoxaban with the standard of care (SOC) in pediatric subjects with cardiac diseases at risk of thromboembolic complications who need primary or secondary anticoagulant prophylaxis with regard to t...

Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures
https://clinicaltrials.gov/ct2/show/NCT05079087

Oct 15th, 2021 - Pertrochanteric femoral fracture is a frequent orthopaedic emergency in the elderly and is associated with significant morbidity and mortality. Surgical reduction and subsequent fixation is the definitive therapy for most patients. Recent clinical...

Unleash the Mystery of COVID-19 Related Unusual Thrombosis
https://clinicaltrials.gov/ct2/show/NCT05068375

Oct 11th, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China in December of 2019, has become a worldwide pandemic with widespread illness and mortality. Clinical manifestations of Coronavirus disease 2019 (COVID-1...

Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event
https://clinicaltrials.gov/ct2/show/NCT05073666

Oct 11th, 2021 - Venous thromboembolic disease (VTE) is a common clinical entity whose two manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE). After an acute PE, almost half of the patients complain residual dyspnea, despite well-conducted c...

see more →

News  892 results

D-dimer Unreliable for Ruling Out Pulmonary Embolism in COVID-19
https://www.medscape.com/viewarticle/960826

Oct 13th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out pulmonary embolism (PE) in critically ill patients for ...

Balancing the Risk and Benefit of Anticoagulation in Patients on BTKi
https://www.onclive.com/view/balancing-the-risk-and-benefit-of-anticoagulation-in-patients-on-btki

Oct 7th, 2021 - Farrukh Awan, MD: We’ll keep talking about specific things. I’ll tell you a few specific issues that I deal with. I’m sure a lot of people in the audience might have to deal with these issues. I’ve had problems, and I’ve had discussions, arguments...

Brentuximab Vedotin Should Not Be Combined With Bleomycin in First-Line Treatment of Hodgkin Lymphoma
https://www.onclive.com/view/brentuximab-vedotin-should-not-be-combined-with-bleomycin-in-first-line-treatment-of-hodgkin-lymphoma

Oct 6th, 2021 - Anas Younes, MD Brentuximab vedotin (Adcetris) should not be given with bleomycin as a first-line therapy for patients with advanced-stage Hodgkin lymphoma, according to a phase I study comparing the agent in combination with standard (ABVD) or m...

Fast Five Quiz: Deep Vein Thrombosis (DVT)
https://www.medscape.com/viewarticle/956728

Aug 23rd, 2021 - Deep vein thrombosis (DVT) is the presence of coagulated blood, a thrombus, in one of the deep venous conduits that return blood to the heart. The clinical conundrum is that symptoms (pain and swelling) are often nonspecific or absent. If left unt...

More Sartan Troubles; Fumbling Action on HeartWare; Bariatric Surgery for High BP?
https://www.medpagetoday.com/cardiology/prevention/93978

Aug 10th, 2021 - Another round of sartan recalls due to impurity concerns is underway in Canada, Korea, and the U.K. (FiercePharma) Boston Scientific is pulling Ingenio pacemakers and cardiac resynchronization therapy pacemakers for inappropriately entering safety...

see more →

Patient Education  5 results see all →